RASSF1A METHYLATION ENHANCES K-RAS MUTATIONS IN BLOCKING EGFR PATHWAY

被引:0
|
作者
Pinto, R. [1 ]
Petriella, D. [1 ]
Silvestris, N. [2 ]
Danza, K. [1 ]
Zito, F. [3 ]
Pilato, B. [1 ]
Lacalamita, R. [1 ]
Colucci, G. [2 ]
Paradiso, A. [1 ]
Tommasi, S. [1 ]
机构
[1] Natl Canc Ctr, Clin Expt Oncol Lab, Bari, Italy
[2] Natl Canc Ctr, Dept Med Oncol, Bari, Italy
[3] Natl Canc Ctr, Dept Anatomopathol, Bari, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:186 / 186
页数:1
相关论文
共 50 条
  • [41] IS THE RASSF1A/HIPPO PATHWAY AT THE BEGINNING OF GLIOMA?
    Levallet, G.
    Planchard, G.
    Duguet, A. E.
    Emery, E.
    Guillamo, J.
    Geffrelot, J.
    Zalcman, G.
    Lechapt-Zalcman, E.
    NEURO-ONCOLOGY, 2012, 14 : 19 - 19
  • [42] Effect of blocking Ras signaling pathway with K-Ras siRNA on apoptosis in esophageal squamous carcinoma cells
    Wang, Xinjie
    Zheng, Yuling
    Fan, Qingxia
    Zhang, Xudong
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2013, 33 (03) : 361 - 366
  • [43] EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition
    Virginia Rotella
    Lorenzo Fornaro
    Enrico Vasile
    Carmelo Tibaldi
    Laura Boldrini
    Antonio Chella
    Armida D'Incecco
    Giovanna Cirigliano
    Aldo Chioni
    Cristiana Lupi
    Elisa Sensi
    Laura Ginocchi
    Simona Giovannelli
    Maria Cristina Pennucci
    Gabriella Fontanini
    Editta Baldini
    Journal of Experimental & Clinical Cancer Research, 33
  • [44] EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition
    Rotella, Virginia
    Fornaro, Lorenzo
    Vasile, Enrico
    Tibaldi, Carmelo
    Boldrini, Laura
    Chella, Antonio
    D'Incecco, Armida
    Cirigliano, Giovanna
    Chioni, Aldo
    Lupi, Cristiana
    Sensi, Elisa
    Ginocchi, Laura
    Giovannelli, Simona
    Pennucci, Maria Cristina
    Fontanini, Gabriella
    Baldini, Editta
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33
  • [45] Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer
    Milano, G.
    Etienne-Grimaldi, M. -C.
    Dahan, L.
    Francoual, M.
    Spano, J. -P.
    Benchimol, D.
    Chazal, M.
    Letoublon, C.
    Andre, T.
    Gilly, F. -N.
    Delpero, J. -R.
    Formento, J. -L.
    ANNALS OF ONCOLOGY, 2008, 19 (12) : 2033 - 2038
  • [46] Uneven locational distribution of colorectal adenomas carrying K-RAS/Braf mutation and Rassf2 methylation
    Harada, Keita
    Kato, Jun
    Hiraoka, Sakiko
    Horii, Joichiro
    Fujuta, Hideyuki
    Shiratori, Yasushi
    GASTROENTEROLOGY, 2007, 132 (04) : A320 - A320
  • [47] Association of K-ras mutations with p16 methylation in human colon cancer
    Guan, RJ
    Fu, Y
    Holt, PR
    Pardee, AB
    GASTROENTEROLOGY, 1999, 116 (04) : A415 - A415
  • [48] Association of K-ras mutations with p16 methylation in human colon cancer
    Guan, RJ
    Fu, YN
    Holt, PR
    Pardee, AB
    GASTROENTEROLOGY, 1999, 116 (05) : 1063 - 1071
  • [49] EGFR and K-Ras mutations and resistance of lung cancer to the IGF-1R tyrosine kinase inhibitors
    Kim, Woo-Young
    Jin, Quanri
    Prudkin, Ludmilla
    Kim, Jin-Soo
    Morgillo, Floriana
    Feng, Lei
    Kim, Edward S.
    Hennessy, Bryan
    Lee, Ju-Seog
    Mills, Gordon
    Lee, J. J.
    Glisson, Bonnie
    Lippman, Scott M.
    Wistuba, Ignacio I.
    Lee, Ho-Young
    CANCER RESEARCH, 2010, 70
  • [50] Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA
    Marchese, Rodolfo
    Muleti, Alessandra
    Pasqualetti, Patrizio
    Bucci, Barbara
    Stigliano, Antonio
    Brunetti, Ercole
    De Angelis, Monica
    Mazzoni, Gianluca
    Tocchi, Adriano
    Brozzetti, Stefania
    PANCREAS, 2006, 32 (02) : 171 - 177